242 related articles for article (PubMed ID: 23416123)
1. Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil.
Torres DC; Ribeiro-Alves M; Romero GA; Dávila AM; Cupolillo E
Acta Trop; 2013 May; 126(2):132-41. PubMed ID: 23416123
[TBL] [Abstract][Full Text] [Related]
2. Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes.
Torres DC; Adaui V; Ribeiro-Alves M; Romero GA; Arévalo J; Cupolillo E; Dujardin JC
Infect Genet Evol; 2010 Aug; 10(6):727-33. PubMed ID: 20478409
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
[TBL] [Abstract][Full Text] [Related]
4. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
[TBL] [Abstract][Full Text] [Related]
5. Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study.
Gagini T; de Oliveira Schubach A; de Fatima Madeira M; Maria Valete-Rosalino C; Fernandes Pimentel MI; da Silva Pacheco R
Parasite; 2017; 24():34. PubMed ID: 28959938
[TBL] [Abstract][Full Text] [Related]
6. In vitro characterization of Leishmania (Viannia) braziliensis isolates from patients with different responses to Glucantime(®) treatment from Northwest Paraná, Brazil.
Fernandes AC; Pedroso RB; de Mello TF; Donatti L; Venazzi EA; Demarchi IG; Aristides SM; Lonardoni MV; Silveira TG
Exp Parasitol; 2016 Aug; 167():83-93. PubMed ID: 27181585
[TBL] [Abstract][Full Text] [Related]
7. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients.
Silva SC; Guimarães LH; Silva JA; Magalhães V; Medina L; Queiroz A; Machado PRL; Schriefer A
Acta Trop; 2018 Feb; 178():34-39. PubMed ID: 29042262
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Sensitivity of Cutaneous
Ginouvès M; Simon S; Nacher M; Demar M; Carme B; Couppié P; Prévot G
Am J Trop Med Hyg; 2017 May; 96(5):1143-1150. PubMed ID: 28167598
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
Grogl M; Thomason TN; Franke ED
Am J Trop Med Hyg; 1992 Jul; 47(1):117-26. PubMed ID: 1322070
[TBL] [Abstract][Full Text] [Related]
11. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.
Arevalo J; Ramirez L; Adaui V; Zimic M; Tulliano G; Miranda-Verástegui C; Lazo M; Loayza-Muro R; De Doncker S; Maurer A; Chappuis F; Dujardin JC; Llanos-Cuentas A
J Infect Dis; 2007 Jun; 195(12):1846-51. PubMed ID: 17492601
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.
Romero GA; Guerra MV; Paes MG; Macêdo VO
Am J Trop Med Hyg; 2001 Nov; 65(5):456-65. PubMed ID: 11716098
[TBL] [Abstract][Full Text] [Related]
13. Mucosal leishmaniasis: A forgotten disease, description and identification of species in 50 Colombian cases.
Muvdi-Arenas S; Ovalle-Bracho C
Biomedica; 2019 Aug; 39(Supl. 2):58-65. PubMed ID: 31529834
[TBL] [Abstract][Full Text] [Related]
14. Molecular identification of the parasites causing cutaneous leishmaniasis on the Caribbean coast of Colombia.
Martínez LP; Rebollo JA; Luna AL; Cochero S; Bejarano EE
Parasitol Res; 2010 Feb; 106(3):647-52. PubMed ID: 20084397
[TBL] [Abstract][Full Text] [Related]
15. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
Rojas R; Valderrama L; Valderrama M; Varona MX; Ouellette M; Saravia NG
J Infect Dis; 2006 May; 193(10):1375-83. PubMed ID: 16619185
[TBL] [Abstract][Full Text] [Related]
16. Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach.
Kazemi-Rad E; Mohebali M; Khadem-Erfan MB; Saffari M; Raoofian R; Hajjaran H; Hadighi R; Khamesipour A; Rezaie S; Abedkhojasteh H; Heidari M
Exp Parasitol; 2013 Oct; 135(2):344-9. PubMed ID: 23928349
[TBL] [Abstract][Full Text] [Related]
17. Multilocus genotyping reveals a polyphyletic pattern among naturally antimony-resistant Leishmania braziliensis isolates from Peru.
Adaui V; Maes I; Huyse T; Van den Broeck F; Talledo M; Kuhls K; De Doncker S; Maes L; Llanos-Cuentas A; Schönian G; Arevalo J; Dujardin JC
Infect Genet Evol; 2011 Dec; 11(8):1873-80. PubMed ID: 21871584
[TBL] [Abstract][Full Text] [Related]
18. First case of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Suriname.
Hu RV; Kent AD; Adams ER; van der Veer C; Sabajo LO; Mans DR; de Vries HJ; Schallig HD; Lai A Fat RF
Am J Trop Med Hyg; 2012 May; 86(5):825-7. PubMed ID: 22556081
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of activated protein kinase C gene (LACK1) in antimony sensitive and resistant Leishmania tropica clinical isolates using real-time RT-PCR.
Hajjaran H; Kazemi-Rad E; Mohebali M; Oshaghi MA; Khadem-Erfan MB; Hajaliloo E; Reisi Nafchi H; Raoofian R
Int J Dermatol; 2016 Sep; 55(9):1020-6. PubMed ID: 27336481
[TBL] [Abstract][Full Text] [Related]
20. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
Teva A; Porrozzi R; Oliveira-Neto MP; Grimaldi GJ
J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
